WednesdaySep 11, 2019 2:16 pm

QualityStocksNewsBreaks – Geyser Brands Inc.’s (TSX.V: GYSR) NanoFusion Technology Provides Competitive Edge

Geyser Brands (TSX.V: GYSR) has developed its proprietary NanoFusion advanced delivery-system technology using natural materials to improve the transportation and delivery of active ingredients. Geyser’s NanoFusion is currently the only natural nanoemulsion on the market featuring no solvents or inflammatory agents. A recent article discussing the company reads, “Apart from ensuring a high level of bioavailability, the NanoFusion technology also increases the shelf life of cannabis products. In addition, it makes it possible for consumers to rely on lower doses to obtain optimal therapeutic benefits from a product. . . . All of the products featured in Geyser’s diversified portfolio…

Continue Reading

WednesdaySep 11, 2019 10:24 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Increase in U.S. County Purchase Order to Over $1 Million for Uniden UV350

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of an additional purchase order from its first U.S. customer to equip their fleet of yellow school buses with its Uniden® UV350, bringing the total order to over $1MM. The county will also begin trials of the UV350 across additional first responder verticals to benefit from unified communication on a dedicated first responder nationwide cellular network. “A major selling point of the UV350 is its nationwide coverage and the ability for various first responder groups to instantly communicate with one another on the same network,” Siyata Mobile CEO Marc Seelenfreund…

Continue Reading

WednesdaySep 11, 2019 10:17 am

QualityStocksNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) TUSC2 Found to Prevent Tumor Growth in Triple-Negative Breast Cancer by Independent Researchers

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that non-affiliated, independent researchers have reported in a recent study that TUSC2, a tumor suppressor gene and the active agent in Genprex’s Oncoprex(TM) immunogene therapy, prevented tumor growth in triple-negative breast cancer (“TNBC”). Currently considered an incurable cancer, there are limited therapeutic options available for TNBC. “The results of the study evaluating TUSC2 for the treatment of triple-negative breast cancer are encouraging,” Genprex Chairman and CEO Rodney Varner said in the news release. “We believe that the data reported in this Nature article by independent researchers supports our belief that…

Continue Reading

WednesdaySep 11, 2019 9:40 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Formation of Strategic Advisory Board

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the formation of its Strategic Advisory Board. According to the update, the group of respected business leaders, which includes inaugural board members John Ruffolo, Meg Lovell and Philip Donne, will provide guidance to Canopy Rivers’ executive team as it continues to build and strengthen its global portfolio of leading cannabis companies. “We have assembled a group of outstanding individuals with exceptional track records as leaders in their respective industries,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “The Strategic Advisory Board…

Continue Reading

WednesdaySep 11, 2019 9:33 am

QualityStocksNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Appoints Initial Corporate Advisor

California-based Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), this morning announced that on August 16, 2019 the company appointed Justin Costello as Grapefruit’s first non-director corporate advisor and the foundation member of its strategic advisory board. Justin Costello, CEO of GRN Funds, entered into a Corporate Advisory Services Agreement with Grapefruit which stipulates an initial term of one year that will renew automatically for six-month periods, subject to the mutual agreement of the parties. “Dan and I are very grateful to Justin for agreeing to accept our offer and become an official member of the Grapefruit…

Continue Reading

TuesdaySep 10, 2019 3:14 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Highlighted in Comprehensive Research Report

Willow Biosciences (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, was recently covered in a research report by Eight Capital. Per the report, Eight Capital issued a ‘Buy’ rating and a target price of $4.50 for WLLW, determined in part by Willow’s chosen method of cannabinoid production, biosynthesis, which holds the potential to disrupt the industry. The report also detailed upcoming catalysts for the company, including the potential formation of partnerships and agreements; quantitative milestones demonstrating increased throughput of the company’s proprietary yeast strains; planned uplisting to the Toronto Stock…

Continue Reading

TuesdaySep 10, 2019 12:59 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and Potential Use in Clinical Diagnostics

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the publication of two scientific journal articles led by independent teams of scientists in China and Australia. Per the update, the articles reported excellent results with PBI’s Pressure Cycling Technology (“PCT”) platform in processing preserved formalin-fixed paraffin-embedded (“FFPE”) and fresh frozen biopsy tissue samples for discovery and elucidation of cancer biomarkers, as well as potential use in clinical diagnostics based upon these markers. "It is estimated (Nature volume 448, pages 959–962,…

Continue Reading

TuesdaySep 10, 2019 12:27 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Launches Advanced iPower Cultivation Equipment on Amazon.com

Sugarmade (OTCQB: SGMD), a leading supplier of hydroponics and cultivation equipment and resources, this morning announced its new line of "iPower" branded inline duct ventilation fans. The advanced equipment for indoor and hydroponic cultivators is designed for durability, high-performance and affordability is now available for immediate purchase on the company's website at ZenHydro.com and on Amazon.com. "Indoor and greenhouse cultivation is becoming increasingly sophisticated, helping both hobbyists and commercial cultivators maximize output regardless of seasonality or weather conditions,” Jimmy Chan, CEO of Sugarmade, said in the news release. "This sophistication, along with expanding mainstream interest in products derived from hemp…

Continue Reading

TuesdaySep 10, 2019 12:07 pm

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Appoints Head of New Sales Division to Sharpen Focus on CBD for Therapeutic and Pharmaceutical-Grade Products

Innovative biotechnology company Earth Science Tech, Inc. (OTCQB: ETST) today announced that it has established a new sales division to sharpen its focus on CBD for therapeutic and pharmaceutical-grade products. Leading the division will be Erika Franck, who has more than 15 years of experience in the pharmaceuticals and orthopedics industry and has recently served as the company’s clinical and therapeutics sales director. “We are pleased to have Erika’s leadership in this important vertical segment. She brings a wealth of knowledge and experience to the team that will be invaluable as we pursue opportunities through this exciting new sales channel,”…

Continue Reading

TuesdaySep 10, 2019 11:49 am

QualityStocksNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Acquires Cultivation, Fulfillment and Production Facility, Expands Arizona Footprint

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced the closing of its acquisition of a 44,000 square foot cultivation, production and fulfillment facility located in Camp Verde, Arizona near Phoenix. This is the company’s second announced acquisition in the state of Arizona following its definitive agreement to acquire a licensed medical marijuana business including a Phoenix dispensary. “We are excited to progress on our growth strategy in Arizona with the purchase of the Camp Verde facility in keeping with  our mission…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered